期刊文献+

2013—2015年天津市人民医院麻醉药品的使用情况分析 被引量:5

Analysis on use of narcotics drugs in Tianjin People's Hospital from 2013 to 2015
原文传递
导出
摘要 目的分析天津市人民医院麻醉药品的使用情况。方法对2013—2015年天津市人民医院麻醉药品的用量、销售金额、用药频度(DDDs)、日均药费(DDC)进行统计和分析。结果天津市人民医院麻醉药品的品种稳定,总销售金额和构成比均逐年增加;芬太尼透皮贴、盐酸羟考酮缓释片、注射用盐酸瑞芬太尼用量、销售金额、DDDs呈较大幅增长趋势,盐酸哌替啶注射液、盐酸布桂嗪片、盐酸氯胺酮注射液则减少,其余则基本不变或小幅加减;硫酸吗啡缓释片的DDDs持续居第1位,盐酸氯胺酮注射液DDDs居末位;麻醉药品的DDC基本稳定不变,注射用盐酸瑞芬太尼DDC最高,盐酸氯胺酮注射液最低。结论天津市人民医院麻醉药品的应用基本合理,但仍存在一些问题,需持续改进。 Objective To investigate the usage of narcotics drugs in Tianjin People’s Hospital. Methods The amount, consumption sum, frequency of drug use (DDDs) and defined daily cost (DDC) of narcotic drugs in Tianjin People’s Hospital from 2013 to 2015 were calculated and analyzed. Results The main kind of narcotic drugs remained stable, and the consumption sum and constituent ratios increased year by year. The utilization and consumption sum and DDDs of Fentanyl Transdermal Patches, Oxycodone Hydrochloride Prolonged-release Tablets, and Remifentanil Hydrochloride for Injection significantly increased, Pethidine Hydrochloride Injection, Bucinnazine Hydrochloride Tablets, and Ketamine Hydrochloride Injection reduced, while others were stable or increased slightly. DDDs of Morphine Sulfate Sustained Release Tablets ranked the first persistently, and Ketamine Hydrochloride Injection ranked the end. DDC of narcotic drugs were stable substantially. Remifentanil Hydrochloride for Injection ranked the first, while Ketamine Hydrochloride Injection ranked the end. Conclusion The utilization of narcotic drugs in Tianjin People’s Hospital is rational on the whole, but there are still some problems, which needs further efforts to strengthen the management and intervention.
出处 《现代药物与临床》 CAS 2016年第9期1500-1504,共5页 Drugs & Clinic
关键词 麻醉药品 用药频度 日均药费 用药分析 narcotic drugs frequency of drug use defined daily cost analysis of drug use
  • 相关文献

参考文献13

  • 1Shaheen P E, Legrand S B, Walsh D, et al. Errors in opioid prescribing: a prospective survey in cancer pain [J]. JPain Symptom Manage, 2010, 39(4): 702-711.
  • 2Apolone G, Corli O, Caraceni A, et al. Pattern and quality of care of cancer pain management.Results from the Cancer Pain Outcome Research Study Group [J]. Br J Cancer, 2009, 100(10): 1566-1574.
  • 3王玉珠,萧惠来.FDA对防滥用阿片类药物研究的要求[J].现代药物与临床,2014,29(11):1311-1317. 被引量:11
  • 4李小梅,李虹义,肖文华,刘端祺.癌症患者疼痛量表的应用[J].中国肿瘤临床,2013,40(24):1482-1486. 被引量:68
  • 5American Pain Society. Guideline for the Management of Cancer pain in Adults and Children [S]. 2005.
  • 6European Association of Urology. Guideline on Pain Management [S]. 2007.
  • 7Quigley C. The role of opioids in cancer pain [J]. BMJ, 2005, 331(7520): 825-829.
  • 8Hanks G W, Conno F, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations [J]. Br J Cancer, 2001, 84(5): 587-593.
  • 9Ant6n A, Montalar J, Carulla J, et al. Pain in clinical oncology: patient satisfaction with management of cancer pain [J]. Eur JPain, 2012, 16(3): 381-389.
  • 10武林鑫,孙莉.癌痛治疗不足的现状与原因[J].肿瘤防治研究,2014,41(4):421-424. 被引量:78

二级参考文献46

  • 1王彦昌.阿片类药物滥用380例临床分析[J].中华腹部疾病杂志,2004,4(12):884-885. 被引量:1
  • 2余汉华,周莉红.临床麻醉性镇痛药应用分析[J].中国医院药学杂志,2005,25(4):354-355. 被引量:24
  • 3陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 4卫生部.关于印发《麻醉药品临床应用指导》的通知[S].卫医发[2007]38号.
  • 5Hjermstad MJ, Fayers PM, Haugen DF, et al. Studies compar- ing Ntmaerical Rating Scales, Verbal Rating Scales, and Visual Ana- logue Scales for assessment of pain intensity in adults: systematic lit- erature review[J].J Pain Symptom Manage. 2011, 41(6):1073-1093.
  • 6Hjermstad MJ, Gibbins J, Hangen DF, et al. Pain assessment tools in palliative care: an urgent need for consensus[]]. Palliat Med. 2008, 22 (8) :895-903.
  • 7Melzack R. The McGiU Pain Questionnaire: Major properties and scoring methods[J]. Pain.1975, 1:277-299.
  • 8Melzack R. The short-form McGiU Pain {~aestionnaire[J]. Pain. 1987, 30(2):191-197.
  • 9Dworkin RH, Turk DC, Revicki DA, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPI~-2)[J]. Pain. 2009, 144:35-42.
  • 10Daut R_L, Cleeland CS, Flanery RC. Development of the Wiscon- sin Brief Pain O~estionnaire to assess pain in cancer and other dis- eases[J]. Pain, 1983, 17:197-210.

共引文献155

同被引文献32

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部